Quality and Regulatory Support Across High-Stakes Regulated Markets
Different sectors carry different rules, evidence expectations and commercial risks. The common thread is the same: the business needs to move forward without making a Quality or Regulatory decision it cannot defend later.
MedTech & Digital Health
Medical devices, SaMD, digital health platforms and connected products preparing for FDA, EU MDR, UK or broader market entry.
Typical needs include 510(k), De Novo and regulatory pathway strategy, technical documentation, clinical and performance evidence, design and software lifecycle controls, ISO 13485, UDI/GUDID, supplier readiness and Quality System maturity.
Pharma, Biotech & CDMO
Pharmaceutical, biologics, biotechnology and contract manufacturing organizations operating under GxP expectations.
Typical needs include CAPA, investigations, change control, data integrity, supplier quality, audit and inspection readiness, validation, computerized systems, annual product review, remediation and scalable Quality governance.
GxP SaaS, AI & Digital Systems
GxP SaaS, AI and Regulatory Technology companies needing senior QA/RA domain expertise, together with regulated organizations implementing systems that support GxP processes, records or decisions.
Typical needs include intended-use definition, CSA and risk-based validation, Part 11 and Annex 11, audit trails, electronic signatures, data integrity, AI benchmark and output evaluation, rubrics, acceptance criteria, unsupported-inference testing, human oversight, traceability, AI governance and enterprise-customer readiness.
Consumer Products & Marketplace Compliance
Brands, manufacturers and marketplace sellers operating in categories where claims, labeling, product safety and documentation can create regulatory or commercial exposure.
Typical needs include cosmetics and MoCRA, EU cosmetics, supplements, claims substantiation, FTC risk, Amazon compliance, import and supplier documentation, FSVP and marketplace launch readiness.
Not Sure Whether Your Situation Fits?
Start with the business decision, not the category label. If the issue sits at the intersection of evidence, Quality, regulatory risk and commercial readiness, it is likely within scope.